Published 30 September 2015 by Juan Ramón Rallo
The decision of Martin Shkreli, the executive director of Turing Pharmaceuticals, to multiply the price of Daraprim, a drug used to treat malaria, toxoplasmosis or HIV, 55-fold has been one of the most notorious pharmaceutical scandals of recent days. The price of a Daraprim pill has gone from 13.5 USD to 750 USD. If the figures seem shocking, add to this the fact that a single Daraprim pill costs less than a USD to produce: in fact, they’re sold in India for about five cents eachContinue Reading